BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 27356124)

  • 1. Myostatin and carbohydrate disturbances.
    Assyov YS; Velikova TV; Kamenov ZA
    Endocr Res; 2017 May; 42(2):102-109. PubMed ID: 27356124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irisin in the Glucose Continuum.
    Assyov Y; Gateva A; Tsakova A; Kamenov Z
    Exp Clin Endocrinol Diabetes; 2016 Jan; 124(1):22-7. PubMed ID: 26479549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased circulating myostatin in patients with type 2 diabetes mellitus.
    Wang F; Liao Y; Li X; Ren C; Cheng C; Ren Y
    J Huazhong Univ Sci Technolog Med Sci; 2012 Aug; 32(4):534-539. PubMed ID: 22886966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between myostatin and irisin in type 2 diabetes mellitus: a compensatory mechanism to an unfavourable metabolic state?
    García-Fontana B; Reyes-García R; Morales-Santana S; Ávila-Rubio V; Muñoz-Garach A; Rozas-Moreno P; Muñoz-Torres M
    Endocrine; 2016 Apr; 52(1):54-62. PubMed ID: 26438394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood microRNA-15a is a potential biomarker for type 2 diabetes mellitus and pre-diabetes.
    Al-Kafaji G; Al-Mahroos G; Alsayed NA; Hasan ZA; Nawaz S; Bakhiet M
    Mol Med Rep; 2015 Nov; 12(5):7485-90. PubMed ID: 26460159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum ferritin and glucose homeostasis: change in the association by glycaemic state.
    Aregbesola A; Virtanen JK; Voutilainen S; Mursu J; Lagundoye A; Kauhanen J; Tuomainen TP
    Diabetes Metab Res Rev; 2015 Jul; 31(5):507-14. PubMed ID: 25470760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role of liver enzyme levels as predictive markers of glucose metabolism disorders in a Tunisian population.
    Bouhajja H; Abdelhedi R; Amouri A; Hadj Kacem F; Marrakchi R; Safi W; Mrabet H; Chtourou L; Charfi N; Fourati M; Bensassi S; Jamoussi K; Abid M; Ayadi H; Mnif-Feki M; Bougacha-Elleuch N
    Can J Physiol Pharmacol; 2018 Nov; 96(11):1171-1180. PubMed ID: 29527933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating levels and characterization of microparticles in patients with different degrees of glucose tolerance.
    Giannella A; Radu CM; Franco L; Campello E; Simioni P; Avogaro A; de Kreutzenberg SV; Ceolotto G
    Cardiovasc Diabetol; 2017 Sep; 16(1):118. PubMed ID: 28927403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study.
    Kong L; Zhu J; Han W; Jiang X; Xu M; Zhao Y; Dong Q; Pang Z; Guan Q; Gao L; Zhao J; Zhao L
    Acta Diabetol; 2011 Mar; 48(1):61-9. PubMed ID: 20857148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasting plasma glucose as initial screening for diabetes and prediabetes in irish adults: The Diabetes Mellitus and Vascular health initiative (DMVhi).
    Sinnott M; Kinsley BT; Jackson AD; Walsh C; O'Grady T; Nolan JJ; Gaffney P; Boran G; Kelleher C; Carr B
    PLoS One; 2015; 10(4):e0122704. PubMed ID: 25874867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance training attenuates circulating FGF-21 and myostatin and improves insulin resistance in elderly men with and without type 2 diabetes mellitus: A randomised controlled clinical trial.
    Shabkhiz F; Khalafi M; Rosenkranz S; Karimi P; Moghadami K
    Eur J Sport Sci; 2021 Apr; 21(4):636-645. PubMed ID: 32345132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Insulin Resistance and β-Cell Dysfunction Between the Young and the Elderly in Normal Glucose Tolerance and Prediabetes Population: A Prospective Study.
    Chen G; Shi L; Cai L; Lin W; Huang H; Liang J; Li L; Lin L; Tang K; Chen L; Lu J; Bi Y; Wang W; Ning G; Wen J
    Horm Metab Res; 2017 Feb; 49(2):135-141. PubMed ID: 27459384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of weight and weight change on normalization of prediabetes and on persistence of normal glucose tolerance in an older population: the KORA S4/F4 study.
    Kowall B; Rathmann W; Heier M; Holle R; Peters A; Thorand B; Herder C; Strassburger K; Giani G; Meisinger C
    Int J Obes (Lond); 2012 Jun; 36(6):826-33. PubMed ID: 21863002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum preadipocyte factor 1 concentrations and risk of developing diabetes: a nested case-control study.
    Lee SH; Rhee M; Yang HK; Ha HS; Lee JH; Kwon HS; Park YM; Yim HW; Kang MI; Lee WC; Son HY; Yoon KH
    Diabet Med; 2016 May; 33(5):631-8. PubMed ID: 26220259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid risk factors among elderly with normal fasting glucose, impaired fasting glucose and type 2 diabetes mellitus. The Italian longitudinal study on aging.
    Noale M; Maggi S; Zanoni S; Limongi F; Zambon S; Crepaldi G
    Nutr Metab Cardiovasc Dis; 2013 Mar; 23(3):220-6. PubMed ID: 21937208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal glycemic profiles by CGMS in obese first-degree relatives of type 2 diabetes mellitus patients.
    Madhu SV; Muduli SK; Avasthi R
    Diabetes Technol Ther; 2013 Jun; 15(6):461-5. PubMed ID: 23631606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study.
    Bianchi C; Miccoli R; Bonadonna RC; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Alviggi L; Gnasso A; Consoli A; Cavalot F; Cavallo MG; Leonetti F; Giaccari A; Del Prato S;
    Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):699-705. PubMed ID: 21291660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-18 Serum Levels in Patients with Obesity, Prediabetes and Newly Diagnosed Type 2 Diabetes.
    Nedeva I; Gateva A; Assyov Y; Karamfilova V; Hristova J; Yamanishi K; Kamenov Z; Okamura H
    Iran J Immunol; 2022 Jun; 19(2):193-200. PubMed ID: 35767893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between insulin resistance and β-cell dysfunction in subphenotypes of prediabetes and type 2 diabetes.
    Færch K; Johansen NB; Witte DR; Lauritzen T; Jørgensen ME; Vistisen D
    J Clin Endocrinol Metab; 2015 Feb; 100(2):707-16. PubMed ID: 25387263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of diabetes and prediabetes on the short-term prognosis in patients with acute ischemic stroke.
    Tanaka R; Ueno Y; Miyamoto N; Yamashiro K; Tanaka Y; Shimura H; Hattori N; Urabe T
    J Neurol Sci; 2013 Sep; 332(1-2):45-50. PubMed ID: 23810779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.